Synergistic antiviral activity against drug-resistant HIV-1 by naturally occurring dipeptide and A single-stranded oligonucleotide

被引:4
作者
Cena-Diez, Rafael [1 ]
Spetz, Anna-Lena [2 ]
Sonnerborg, Anders [1 ,3 ]
机构
[1] Karolinska Inst, Dept Med Huddinge, Div Infect Dis, ANA Futura, Alfred Nobels Alle 8, S-14152 Huddinge, Sweden
[2] Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, S-10691 Stockholm, Sweden
[3] Karolinska Inst, Dept Lab Med, Div Clin Microbiol, S-14152 Huddinge, Sweden
基金
瑞典研究理事会;
关键词
Dipeptide; SsON; Combination; Synergy; HIV; Drug resistance; INSTI;
D O I
10.1016/j.drup.2023.100955
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The novel dipeptide WG-am and single-stranded oligonucleotide combination (WG-am:ssON) showed synergistic antiviral activity against HIV-1 integrase-, protease-or reverse transcriptase drug resistant isolates, with over 95% reduction. The highest selectivity indexes were for integrase resistant isolates. WG-am:ssON can be a future option for treatment of HIV drug-resistant strains.
引用
收藏
页数:3
相关论文
共 10 条
[1]   Novel Naturally Occurring Dipeptides and Single-Stranded Oligonucleotide Act as Entry Inhibitors and Exhibit a Strong Synergistic Anti-HIV-1 Profile [J].
Cena-Diez, Rafael ;
Singh, Kamalendra ;
Spetz, Anna-Lena ;
Sonnerborg, Anders .
INFECTIOUS DISEASES AND THERAPY, 2022, 11 (03) :1103-1116
[2]   QUANTITATIVE-ANALYSIS OF DOSE-EFFECT RELATIONSHIPS - THE COMBINED EFFECTS OF MULTIPLE-DRUGS OR ENZYME-INHIBITORS [J].
CHOU, TC ;
TALALAY, P .
ADVANCES IN ENZYME REGULATION, 1984, 22 :27-55
[3]   Exploring predictors of HIV-1 virologic failure to long-acting cabotegravir and rilpivirine: a multivariable analysis [J].
Cutrell, Amy G. ;
Schapiro, Jonathan M. ;
Perno, Carlo F. ;
Kuritzkes, Daniel R. ;
Quercia, Romina ;
Patel, Parul ;
Polli, Joseph W. ;
Dorey, David ;
Wang, Yongwei ;
Wu, Sterling ;
Van Eygen, Veerle ;
Crauwels, Herta ;
Ford, Susan L. ;
Baker, Mark ;
Talarico, Christine L. ;
St Clair, Marty ;
Jeffrey, Jerry ;
White, C. Thomas ;
Vanveggel, Simon ;
Vandermeulen, Kati ;
Margolis, David A. ;
Aboud, Michael ;
Spreen, William R. ;
van Lunzen, Jan .
AIDS, 2021, 35 (09) :1333-1342
[4]   High-level dolutegravir resistance can emerge rapidly from few variants and spread by recombination: implications for INSTI salvage therapy [J].
Duarte, Frederico C. ;
Moura, Luis M. ;
Laranjinha, Joana .
AIDS, 2022, 36 (13) :1881-1882
[5]   Genotypic correlates of resistance to the HIV-1 strand transfer integrase inhibitor cabotegravir [J].
Rhee, Soo-Yon ;
Parkin, Neil ;
Harrigan, P. Richard ;
Holmes, Susan ;
Shafer, Robert W. .
ANTIVIRAL RESEARCH, 2022, 208
[6]   A systematic review of the genetic mechanisms of dolutegravir resistance [J].
Rhee, Soo-Yon ;
Grant, Philip M. ;
Tzou, Philip L. ;
Barrow, Geoffrey ;
Harrigan, P. Richard ;
Ioannidis, John P. A. ;
Shafer, Robert W. .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2019, 74 (11) :3135-3149
[7]   Comparable In Vitro Activities of Second-Generation HIV-1 Integrase Strand Transfer Inhibitors (INSTIs) on HIV-1 Clinical Isolates with INSTI Resistance Mutations [J].
Saladini, Francesco ;
Giannini, Alessia ;
Boccuto, Adele ;
Dragoni, Filippo ;
Appendino, Alice ;
Albanesi, Edoardo ;
Vicenti, Ilaria ;
Zazzi, Maurizio .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (01)
[8]   Fecal Metabolome Signature in the HIV-1 Elite Control Phenotype: Enrichment of Dipeptides Acts as an HIV-1 Antagonist but a Prevotella Agonist [J].
Sperk, Maike ;
Ambikan, Anoop T. ;
Ray, Shilpa ;
Singh, Kamal ;
Mikaeloff, Flora ;
Diez, Rafael Cena ;
Narayanan, Ashwathy ;
Vesterbacka, Jan ;
Nowak, Piotr ;
Sonnerborg, Anders ;
Neogi, Ujjwal .
JOURNAL OF VIROLOGY, 2021, 95 (18)
[9]   Antiviral Characteristics of GSK1265744, an HIV Integrase Inhibitor Dosed Orally or by Long-Acting Injection [J].
Yoshinaga, Tomokazu ;
Kobayashi, Masanori ;
Seki, Takahiro ;
Miki, Shigeru ;
Wakasa-Morimoto, Chiaki ;
Suyama-Kagitani, Akemi ;
Kawauchi-Miki, Shinobu ;
Taishi, Teruhiko ;
Kawasuji, Takashi ;
Johns, Brian A. ;
Underwood, Mark R. ;
Garvey, Edward P. ;
Sato, Akihiko ;
Fujiwara, Tamio .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (01) :397-406
[10]   Accumulation of Multiple Mutations In Vivo Confers Cross-Resistance to New and Existing Integrase Inhibitors [J].
Zhang, Wendy W. ;
Cheung, Peter K. ;
Oliveira, Natalia ;
Robbins, Marjorie A. ;
Harrigan, P. Richard ;
Shahid, Aniqa .
JOURNAL OF INFECTIOUS DISEASES, 2018, 218 (11) :1773-1776